BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28628564)

  • 1. Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors.
    Han S; Yang JD; Sinn DH; Kim JM; Choi GS; Jung G; Ahn JH; Kim S; Ko JS; Gwak MS; Kwon CHD; Leise MD; Gwak GY; Heimbach JK; Kim GS
    Ann Surg; 2018 Dec; 268(6):1043-1050. PubMed ID: 28628564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation.
    Han S; Lee S; Yang JD; Leise MD; Ahn JH; Kim S; Jung K; Gwak MS; Kim GS; Ko JS
    Liver Transpl; 2018 Jan; 24(1):44-55. PubMed ID: 29024412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Han S; Yang JD; Sinn DH; Ko JS; Kim JM; Shin JC; Son HJ; Gwak MS; Joh JW; Kim GS
    Transplantation; 2016 Sep; 100(9):1933-8. PubMed ID: 27362316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death.
    Nakamura T; Sasaki K; Kojima L; Teo R; Inaba Y; Yamamoto T; Kimura S; Dageforde LA; Yeh H; Elias N; Bozorgzadeh A; Kawai T; Markmann JF
    Clin Transplant; 2023 Aug; 37(8):e14989. PubMed ID: 37039506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
    Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
    Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
    Kim SH; Lee EC; Na BG; Park SJ
    Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
    Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.
    Kwon JH; Han S; Jang JS; Lee KW; Ahn JH; Kim K; Jeon S; Gwak MS; Ko JS; Kim GS; Joh JW; Cho D
    Transplantation; 2021 Mar; 105(3):577-585. PubMed ID: 32265418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma.
    Han S; Kim G; Ko JS; Sinn DH; Yang JD; Joh JW; Lee SK; Gwak MS
    Ann Surg; 2016 Aug; 264(2):339-43. PubMed ID: 26501715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
    Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.
    Vagefi PA; Dodge JL; Yao FY; Roberts JP
    Liver Transpl; 2015 Feb; 21(2):187-94. PubMed ID: 25371243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Taketomi A; Fukuhara T; Morita K; Kayashima H; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Maehara Y
    Ann Surg Oncol; 2010 Sep; 17(9):2283-9. PubMed ID: 20204531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
    Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term outcomes of patients with hepatocellular carcinoma after living donor liver transplantation: a comparison of right and left lobe grafts.
    Taketomi A; Shirabe K; Toshima T; Morita K; Hashimoto N; Kayashima H; Ikegami T; Yoshizumi T; Soejima Y; Maehara Y
    Surg Today; 2012 Jun; 42(6):559-64. PubMed ID: 22245925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.